Phase Ia trial of RVX 208 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2009
At a glance
- Drugs Apabetalone (Primary)
- Indications Acute coronary syndromes; Alzheimer's disease; Atherosclerosis; Low HDL cholesterol
- Focus Adverse reactions
- 31 Mar 2009 Results presented at ACC 2009.
- 10 Nov 2008 Results presented at AHA 2008.
- 10 Nov 2008 Resverlogix has reported positive results of an exploratory analysis of effects on amyloid-beta levels.